STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Yatsen Announces Third Quarter 2025 Financial Results

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Negative)
Tags

Yatsen (NYSE:YSG) reported third quarter 2025 unaudited results with total net revenues up 47.5% to RMB998.4 million (US$140.2M) and skincare revenues up 83.2% to RMB490.8 million (US$68.9M), representing 49.2% of revenues. Gross margin rose to 78.2% from 75.9% and gross profit increased 51.9% to RMB780.5 million (US$109.6M). Net loss narrowed by 41.9% to RMB70.4 million (US$9.9M); non-GAAP net loss narrowed 32.8% to RMB51.5 million (US$7.2M). Operating expenses rose 31.9% to RMB864.1 million but fell as a % of revenue to 86.5%. Cash, restricted cash and short-term investments were RMB1.16 billion as of Sept 30, 2025. Q4 2025 revenue guidance: RMB1.32–1.49 billion (approx. +15% to +30% YoY).

Yatsen (NYSE:YSG) ha riportato risultati non auditati del terzo trimestre 2025 con ricavi netti totali in crescita del 47,5% a RMB998,4 milioni (US$140,2 milioni) e ricavi per la cura della pelle in crescita dell'83,2% a RMB490,8 milioni (US$68,9 milioni), rappresentando il 49,2% dei ricavi. Il margine lordo è salito al 78,2% dal 75,9% e l'utile lordo è aumentato del 51,9% a RMB780,5 milioni (US$109,6 milioni). La perdita netta si è ridotta del 41,9% a RMB70,4 milioni (US$9,9 milioni); la perdita netta non GAAP si è ridotta del 32,8% a RMB51,5 milioni (US$7,2 milioni). Le spese operative sono aumentate del 31,9% a RMB864,1 milioni ma la percentuale sui ricavi è scesa al 86,5%. Le disponibilità liquide, contanti ristretti e investimenti a breve termine ammontavano a RMB1,16 miliardi al 30 settembre 2025. Guidance per i ricavi del Q4 2025: RMB1,32–1,49 miliardi (circa +15% a +30% YoY).
Yatsen (NYSE:YSG) reportó resultados no auditados del tercer trimestre de 2025 con ingresos netos totales un 47,5% más, hasta RMB998,4 millones (US$140,2 millones) y ingresos por cuidado de la piel un 83,2% más, hasta RMB490,8 millones (US$68,9 millones), representando el 49,2% de los ingresos. El margen bruto subió al 78,2% desde 75,9% y la utilidad bruta aumentó un 51,9% a RMB780,5 millones (US$109,6 millones). La pérdida neta se redujo un 41,9% a RMB70,4 millones (US$9,9 millones); la pérdida neta no GAAP se redujo un 32,8% a RMB51,5 millones (US$7,2 millones). Los gastos operativos subieron un 31,9% a RMB864,1 millones pero cayeron como porcentaje de los ingresos al 86,5%. Caja, efectivo restringido y inversiones a corto plazo fueron RMB1,16 mil millones al 30 de septiembre de 2025. Guía de ingresos para el Q4 2025: RMB1,32–1,49 mil millones (aprox. +15% a +30% interanual).
Yatsen(NYSE:YSG)가 2025년 3분기 비감사 결과를 발표했습니다. 총 순매출은 전년 동기 대비 47.5% 증가한 RMB9억9840만 위안(미화 1억4020만 달러), 스킨케어 매출은 83.2% 증가한 RMB4억9080만 위안(미화 6890만 달러)으로 매출의 49.2%를 차지했습니다. 총이익률은 78.2%로 75.9%에서 상승했고 매출총이익은 51.9% 증가한 RMB7억8050만 위안(미화 1억96만 달러)으로 증가했습니다. 순손실은 41.9% 감소한 RMB7,040만 위안(미화 990만 달러); 비GAAP 순손실은 32.8% 감소한 RMB5,150만 위안(미화 720만 달러). 영업비용은 31.9% 증가한 RMB8,641만 위안이었지만 매출 대비 비중은 86.5%로 감소했습니다. 2025년 9월 30일 기준 현금, 구제현금 및 단기투자액은 RMB11.6억 위안이었습니다. 2025년 4분기 매출 가이던스: RMB13.2–14.9억 위안(전년동기대비 대략 +15% ~ +30%).
Yatsen (NYSE:YSG) a publié des résultats non audités du troisième trimestre 2025 avec des revenus nets totaux en hausse de 47,5% à 998,4 millions de RMB (140,2 millions de dollars US) et des revenus de soins de la peau en hausse de 83,2% à 490,8 millions de RMB (68,9 millions de dollars US), représentant 49,2% des revenus. La marge brute est passée à 78,2% contre 75,9% et le bénéfice brut a augmenté de 51,9% pour atteindre 780,5 millions de RMB (109,6 millions de dollars US). La perte nette s'est réduite de 41,9% à 70,4 millions de RMB (9,9 millions de dollars US); la perte nette non GAAP s'est réduite de 32,8% à 51,5 millions de RMB (7,2 millions de dollars US). Les dépenses d'exploitation ont augmenté de 31,9% à 864,1 millions de RMB, mais ont diminué en pourcentage des revenus pour atteindre 86,5%. La trésorerie, les liquidités restreintes et les investissements à court terme s'élevaient à 1,16 milliard de RMB au 30 septembre 2025. Prévisions de revenus pour le T4 2025 : 1,32–1,49 milliard RMB (environ +15% à +30% sur un an).
Yatsen (NYSE:YSG) gab die ungeprüften Ergebnisse des dritten Quartals 2025 bekannt, mit einem Gesamtumsatz von 998,4 Mio. RMB (US$140,2 Mio.) und Skin-Care-Umsätzen von 490,8 Mio. RMB (US$68,9 Mio.), was 49,2% des Umsatzes entspricht, sowie einer Brutto Marge von 78,2% (von 75,9%) und einem Bruttogewinn von 780,5 Mio. RMB (US$109,6 Mio.), was einem Anstieg von 51,9% entspricht. Der Nettogewinn verzeichnete eine Reduktion um 41,9% auf RMB70,4 Mio. (US$9,9 Mio.); der nicht-GAAP-Nettoverlust schrumpfte um 32,8% auf RMB51,5 Mio. (US$7,2 Mio.). Die Betriebsausgaben stiegen um 31,9% auf RMB864,1 Mio., aber als Prozentsatz des Umsatzes fielen sie auf 86,5%. Barmittel, eingeschränkte Barmittel und kurzfristige Investments belaufen sich zum 30. September 2025 auf RMB1,16 Milliarden. Umsatzprognose für Q4 2025: RMB1,32–1,49 Milliarden (ca. +15% bis +30% YoY).
أعلنت Yatsen (NYSE:YSG) عن نتائج الربع الثالث من عام 2025 غير المدققة مع ارتفاع إجمالي الإيرادات الصافية بنسبة 47.5% إلى 998.4 مليون يوان صيني (140.2 مليون دولار أمريكي) وإيرادات العناية بالبشرة بنسبة 83.2% إلى 490.8 مليون يوان صيني (68.9 مليون دولار أمريكي)، والتي تمثل 49.2% من الإيرادات. ارتفع هامش الربح الإجمالي إلى 78.2% من 75.9% وزاد الربح الإجمالي بنسبة 51.9% إلى 780.5 مليون يوان صيني (109.6 مليون دولار أمريكي). تقلص صافي الخسارة بنسبة 41.9% إلى 70.4 مليون يوان صيني (9.9 مليون دولار أمريكي)؛ تقلص صافي الخسارة غير المحقق وفق مبدأ GAAP بنسبة 32.8% إلى 51.5 مليون يوان صيني (7.2 مليون دولار أمريكي). ارتفعت المصروفات التشغيلية بنسبة 31.9% إلى 864.1 مليون يوان صيني لكنها انخفضت كنسبة من الإيرادات إلى 86.5%. كانت النقدية، النقد المقيد والاستثمارات قصيرة الأجل 1.16 مليار يوان صيني حتى 30 سبتمبر 2025. توجيه الإيرادات للربع الرابع من 2025: 1.32–1.49 مليار يوان صيني (تقريباً +15% إلى +30% على أساس سنوي).
Positive
  • Total net revenues +47.5% to RMB998.4M in Q3 2025
  • Skincare revenues +83.2% to RMB490.8M in Q3 2025
  • Gross margin expanded to 78.2% from 75.9%
  • Net loss narrowed 41.9% to RMB70.4M
Negative
  • Operating expenses rose 31.9% to RMB864.1M in Q3 2025
  • Cash and equivalents down ~14.7% to RMB1.16B since Dec 31, 2024
  • Company remains loss-making with Q3 net loss margin 7.0%

Insights

Strong revenue growth, margin expansion and narrower losses; guidance implies continued recovery into Q4 2025.

Yatsen delivered a clear top-line acceleration with total net revenues up 47.5% to RMB998.4 million and skincare revenue up 83.2% to RMB490.8 million, lifting gross margin to 78.2%. The company converted higher sales into improved operating efficiency: operating loss narrowed to RMB83.6 million and net loss fell to RMB70.4 million, while non-GAAP losses also improved. These are concrete, money-and-margin improvements that support the narrative of operational progress.

The principal dependencies and risks are explicit in the figures: operating expenses rose to RMB864.1 million (though declined as a percent of revenue), and cash, restricted cash and short-term investments declined to RMB1.16 billion. The outlook for the fourth quarter, which guides revenue between RMB1.32 billion and RMB1.49 billion (approximately 15 to 30 YoY growth), is framed as preliminary and subject to change. Headline improvements rely on continued higher-margin skincare mix, successful product launches and the upcoming Double 11 period.

Watch near-term milestones through the Q4 2025 revenue range and any commentary on cash burn and marketing spend after Double 11; monitor gross-margin sustainability and whether operating expenses continue to leverage higher revenue. The disclosures give measurable items to track: reported revenue, gross margin, operating and non-GAAP loss trends, and cash levels at the next quarterly update.

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on November 17, 2025

GUANGZHOU, China, Nov. 17, 2025 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leading China-based beauty group, today announced its unaudited financial results for the third quarter ended September 30, 2025.

Third Quarter 2025 Highlights

  • Total net revenues for the third quarter of 2025 increased by 47.5% to RMB998.4 million (US$140.2 million) from RMB677.0 million for the prior year period.
  • Total net revenues from Skincare Brands[1] for the third quarter of 2025 increased by 83.2% to RMB490.8 million (US$68.9 million) from RMB267.9 million for the prior year period. As a percentage of total net revenues, total net revenues from Skincare Brands for the third quarter of 2025 were 49.2%, as compared with 39.6% for the prior year period.
  • Gross margin for the third quarter of 2025 increased to 78.2% from 75.9% for the prior year period.
  • Net loss for the third quarter of 2025 narrowed by 41.9% to RMB70.4 million (US$9.9 million) from RMB121.1 million for the prior year period. Non-GAAP net loss[2]for the third quarter of 2025 narrowed by 32.8% to RMB51.5 million (US$7.2 million) from RMB76.6 million for the prior year period.

Mr. Jinfeng Huang, Founder, Chairman and Chief Executive Officer of Yatsen, stated, "Today's results reflect the continued progress of our strategy to build a competitive and resilient brand portfolio. During the third quarter, we once again achieved revenue growth, with our skincare brands significantly outperforming the market. Our major brands continued to introduce new products, for instance, DR.WU's PDRN Serum and Galénic's No.3 VB Serum. Our robust product pipelines have positioned us well for the upcoming Double 11 shopping festival. We remain focused on accelerating brand and product innovation to drive sustainable, long-term growth."

Mr. Donghao Yang, Director and Chief Financial Officer of Yatsen, commented, "Our third quarter total net revenues grew by 47.5% year over year, exceeding our previous guidance. While we made upfront investments in new hero product launches and preparations for the Double 11 shopping festival, our ongoing efforts to enhance gross margin and optimize operating efficiency still led to a meaningful year-over-year improvement in our loss margin. We will continue to refine our cost structure and remain confident in the resources and capabilities supporting the Company's future growth."

Third Quarter 2025 Financial Results

Net Revenues

Total net revenues for the third quarter of 2025 increased by 47.5% to RMB998.4 million (US$140.2 million) from RMB677.0 million for the prior year period. The increase was primarily due to an 83.2% year-over-year increase in net revenues from Skincare Brands, combined with a 25.2% year-over-year increase in net revenues from Color Cosmetics Brands.[3]

Gross Profit and Gross Margin

Gross profit for the third quarter of 2025 increased by 51.9% to RMB780.5 million (US$109.6 million) from RMB513.8 million for the prior year period. Gross margin for the third quarter of 2025 increased to 78.2% from 75.9% for the prior year period. The increase was primarily driven by an increase in sales of higher-gross-margin products.

Operating Expenses

Total operating expenses for the third quarter of 2025 increased by 31.9% to RMB864.1 million (US$121.4 million) from RMB655.2 million for the prior year period. As a percentage of total net revenues, total operating expenses for the third quarter of 2025 were 86.5%, as compared with 96.8% for the prior year period.

  • Fulfillment Expenses. Fulfillment expenses for the third quarter of 2025 were RMB61.8 million (US$8.7 million), as compared with RMB50.4 million for the prior year period. As a percentage of total net revenues, fulfillment expenses for the third quarter of 2025 decreased to 6.2% from 7.4% for the prior year period. The decrease was primarily driven by fulfillment cost optimization, coupled with the leveraging effect of higher total net revenues in the third quarter of 2025.
  • Selling and Marketing Expenses. Selling and marketing expenses for the third quarter of 2025 were RMB682.3 million (US$95.8 million), as compared with RMB494.4 million for the prior year period. As a percentage of total net revenues, selling and marketing expenses for the third quarter of 2025 decreased to 68.3% from 73.0% for the prior year period. The decrease was primarily driven by the leveraging effect of higher total net revenues in the third quarter of 2025.
  • General and Administrative Expenses. General and administrative expenses for the third quarter of 2025 were RMB80.2 million (US$11.3 million), as compared with RMB85.0 million for the prior year period. As a percentage of total net revenues, general and administrative expenses for the third quarter of 2025 decreased to 8.0% from 12.6% for the prior year period. The decrease was primarily driven by lower share-based compensation expenses, coupled with the leveraging effect of higher total net revenues in the third quarter of 2025.
  • Research and Development Expenses. Research and development expenses for the third quarter of 2025 were RMB39.8 million (US$5.6 million), as compared with RMB25.3 million for the prior year period. As a percentage of total net revenues, research and development expenses for the third quarter of 2025 increased to 4.0% from 3.7% for the prior year period. The increase was primarily driven by higher payroll expenses resulting from a rise in research and development headcount.

Loss from Operations

Loss from operations for the third quarter of 2025 was RMB83.6 million (US$11.7 million), as compared with RMB141.3 million for the prior year period. Operating loss margin was 8.4%, as compared with 20.9% for the prior year period.

Non-GAAP loss from operations[4] for the third quarter of 2025 was RMB60.6 million (US$8.5 million), as compared with RMB98.5 million for the prior year period. Non-GAAP operating loss margin[5] was 6.1%, as compared with 14.5% for the prior year period.

Net Loss / Income

Net loss for the third quarter of 2025 was RMB70.4 million (US$9.9 million), as compared with RMB121.1 million for the prior year period. Net loss margin was 7.0%, as compared with 17.9% for the prior year period. Net loss attributable to Yatsen's ordinary shareholders per diluted ADS[6] for the third quarter of 2025 was RMB0.70 (US$0.10), as compared with RMB1.22 for the prior year period.

Non-GAAP net loss for the third quarter of 2025 was RMB51.5 million (US$7.2 million), as compared with RMB76.6 million for the prior year period. Non-GAAP net loss margin was 5.2%, as compared with 11.3% for the prior year period. Non-GAAP net loss attributable to Yatsen's ordinary shareholders per diluted ADS[7] for the third quarter of 2025 was RMB0.50 (US$0.07), as compared with RMB0.77 for the prior year period.

Balance Sheet and Cash Flow

As of September 30, 2025, the Company had cash, restricted cash and short-term investments of RMB1.16 billion (US$162.6 million), as compared with RMB1.36 billion as of December 31, 2024.

Net cash used in operating activities for the third quarter of 2025 was RMB126.8 million (US$17.8 million), as compared with RMB175.9 million for the prior year period.

Business Outlook

For the fourth quarter of 2025, the Company expects its total net revenues to be between RMB1.32 billion and RMB1.49 billion, representing a year-over-year increase of approximately 15% to 30%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change.

Exchange Rate

This announcement contains translations of certain Renminbi ("RMB") amounts into U.S. dollars ("US$") at specified rates solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to US$ were made at a rate of RMB7.1190 to US$1.00, the exchange rate in effect as of September 30, 2025, as set forth in the H.10 statistical release of The Board of Governors of the Federal Reserve System. The Company makes no representation that any RMB or US$ amounts could have been, or could be, converted into US$ or RMB, as the case may be, at any particular rate, or at all.

[1] Include net revenues from Galénic, DR.WU (its mainland China business), Eve Lom and other skincare brands of the Company.

[2] Non-GAAP net income (loss) is a non-GAAP financial measure. Non-GAAP net income (loss) is defined as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill and (v) tax effects on non-GAAP adjustments.

[3] Include Perfect Diary, Little Ondine, Pink Bear and other color cosmetics brands of the Company.

[4] Non-GAAP loss from operations is a non-GAAP financial measure. Non-GAAP loss from operations is defined as loss from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill.

[5] Non-GAAP operating loss margin is a non-GAAP financial measure, which is defined as non-GAAP net loss from operations as a percentage of total net revenues.

[6] ADS refers to American depositary shares, each of which represents twenty Class A ordinary shares.

[7] Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is a non-GAAP financial measure. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is defined as non-GAAP net income (loss) attributable to ordinary shareholders divided by the weighted average number of diluted ADS outstanding for computing diluted earnings per ADS. Non-GAAP net income (loss) attributable to ordinary shareholders is defined as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) tax effects on non-GAAP adjustments and (vi) accretion to redeemable non-controlling interests.

Conference Call Information

The Company's management will hold a conference call on Monday, November 17, 2025, at 7:30 A.M. U.S. Eastern Time or 8:30 P.M. Beijing Time to discuss its financial results and operating performance for the third quarter of 2025.

United States (toll free):

+1-888-346-8982

International:

+1-412-902-4272

Mainland China (toll free):

400-120-1203

Hong Kong, SAR (toll free):

800-905-945

Hong Kong, SAR:

+852-3018-4992

The replay will be accessible through Monday, November 24, by dialing the following numbers:

United States:

+1-877-344-7529

International:

+1-412-317-0088

Replay Access Code:

4338347

A live and archived webcast of the conference call will also be available on the Company's investor relations website at http://ir.yatsenglobal.com.

About Yatsen Holding Limited

Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business) and Eve Lom. The Company's flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly both online and offline, with expansive presence across all major e-commerce, social and content platforms in China.

For more information, please visit http://ir.yatsenglobal.com.

Use of Non-GAAP Financial Measures

The Company uses non-GAAP income (loss) from operations, non-GAAP operating income (loss) margin, non-GAAP net income (loss), non-GAAP net income (loss) margin, non-GAAP net income (loss) attributable to ordinary shareholders and non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS, each a non-GAAP financial measure, in reviewing and assessing its operating performance. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company presents these non-GAAP financial measures because they are used by the management to evaluate operating performance and formulate business plans. Non-GAAP financial measures help identify underlying trends in its business, provide further information about its results of operations, and enhance the overall understanding of its past performance and future prospects. The Company defines non-GAAP income (loss) from operations as income (loss) from operations excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions and (iii) impairment of goodwill. Non-GAAP operating income (loss) margin is non-GAAP income (loss) from operations as a percentage of total net revenues. The Company defines non-GAAP net income (loss) as net income (loss) excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill and (v) tax effects on non-GAAP adjustments. Non-GAAP net income (loss) margin is non-GAAP net income (loss) as a percentage of total net revenues. The Company defines non-GAAP net income (loss) attributable to ordinary shareholders as net income (loss) attributable to ordinary shareholders excluding (i) share-based compensation expenses, (ii) amortization of intangible assets resulting from assets and business acquisitions, (iii) revaluation of investments on the share of equity method investments, (iv) impairment of goodwill, (v) tax effects on non-GAAP adjustments and (vi) accretion to redeemable non-controlling interests. Non-GAAP net income (loss) attributable to ordinary shareholders per diluted ADS is computed using non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of diluted ADS outstanding for computing diluted earnings per ADS.

However, the non-GAAP financial measures have limitations as analytical tools as the non-GAAP financial measures are not presented in accordance with U.S. GAAP and may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measures to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating performance. The Company encourages investors and others to review its financial information in its entirety and not rely on a single financial measure. Reconciliations of Yatsen's non-GAAP financial measure to the most comparable U.S. GAAP measure are included at the end of this press release.

Safe Harbor Statement

This announcement contains statements that may constitute "forward-looking" statements which are made pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "likely to," and similar statements. The Company may also make written or oral forward-looking statements in its periodic reports to the Securities and Exchange Commission ("SEC"), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about the Company's beliefs, plans, outlook and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; its ability to continue to roll out popular products and maintain popularity of existing products; its ability to anticipate and respond to changes in industry trends and consumer preferences and behavior in a timely manner; its ability to attract and retain new customers and to increase revenues generated from repeat customers; its expectations regarding demand for and market acceptance of its products and services; its ability to integrate newly-acquired businesses and brands; trends and competition in and relevant government policies and regulations relating to China's beauty market; changes in its revenues and certain cost or expense items; and general economic conditions globally and in China. Further information regarding these and other risks is included in the Company's filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

For investor and media inquiries, please contact:

Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com

 

 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(All amounts in thousands, except for share, per share data or otherwise noted)






December 31,



September 30,



September 30,




2024



2025



2025




RMB'000



RMB'000



USD'000


Assets










Current assets










Cash and cash equivalents



817,395




690,189




96,950


Restricted Cash



-




119,039




16,721


Short-term investments



539,130




348,170




48,907


Accounts receivable, net



214,558




276,479




38,837


Inventories, net



386,054




479,663




67,378


Prepayments and other current assets



381,404




452,241




63,526


Amounts due from related parties



9,113




64




9


Total current assets



2,347,654




2,365,845




332,328


Non-current assets










Investments



664,579




666,891




93,678


Property and equipment, net



74,373




74,471




10,461


Goodwill, net



155,029




155,029




21,777


Intangible assets, net



559,708




555,570




78,040


Deferred tax assets



1,381




1,453




204


Right-of-use assets, net



147,501




176,530




24,797


Other non-current assets



20,642




24,996




3,511


Total non-current assets



1,623,213




1,654,940




232,468


Total assets



3,970,867




4,020,785




564,796


Liabilities, redeemable non-controlling interests and shareholders' equity










Current liabilities










Accounts and notes payable



72,090




254,244




35,713


Advances from customers



19,574




26,562




3,731


Accrued expenses and other liabilities



460,143




383,480




53,867


Amounts due to related parties



28,884




39,228




5,510


Income tax payables



20,088




16,234




2,280


Lease liabilities due within one year



39,409




52,275




7,343


Total current liabilities



640,188




772,023




108,444


Non-current liabilities










Deferred tax liabilities



103,306




105,252




14,785


Deferred income-non current



14,832




2,665




374


Lease liabilities



109,526




127,697




17,937


Total non-current liabilities



227,664




235,614




33,096


Total liabilities



867,852




1,007,637




141,540


Redeemable non-controlling interests



50,984




1,337




188


Shareholders' equity










Ordinary Shares (US$0.00001 par value; 10,000,000,000 ordinary shares authorized,
comprising of 6,000,000,000 Class A ordinary shares, 960,852,606 Class B ordinary
shares and 3,039,147,394 shares each of such classes to be designated as of December 31,
2024 and September 30, 2025; 2,096,600,883 Class A shares and 600,572,880 Class B
ordinary shares issued as of December 31, 2024 and September 30, 2025; 1,234,627,468
Class A ordinary shares and 600,572,880 Class B ordinary shares outstanding as of
December 31, 2024, 1,279,511,783 Class A ordinary shares and 600,572,880 Class B
ordinary shares outstanding as of September 30, 2025)



173




173




24


Treasury shares



(1,276,330)




(1,242,567)




(174,542)


Additional paid-in capital



12,273,767




12,289,222




1,726,257


Statutory reserve



28,147




28,147




3,954


Accumulated deficit



(8,057,297)




(8,146,230)




(1,144,294)


Accumulated other comprehensive income



86,866




89,682




12,598


Total Yatsen Holding Limited shareholders' equity



3,055,326




3,018,427




423,997


Non-controlling interests



(3,295)




(6,616)




(929)


Total shareholders' equity



3,052,031




3,011,811




423,068


Total liabilities, redeemable non-controlling interests and shareholders' equity



3,970,867




4,020,785




564,796


 

 

YATSEN HOLDING LIMITED

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(All amounts in thousands, except for share, per share data or otherwise noted)






For the Three Months Ended September 30,





2024



2025



2025





RMB'000



RMB'000



USD'000



Total net revenues



677,016




998,416




140,247



Total cost of revenues



(163,191)




(217,934)




(30,613)



Gross profit



513,825




780,482




109,634



Operating expenses:











Fulfilment expenses



(50,412)




(61,770)




(8,677)



Selling and marketing expenses



(494,357)




(682,297)




(95,842)



General and administrative expenses



(85,046)




(80,230)




(11,270)



Research and development expenses



(25,338)




(39,755)




(5,584)



Total operating expenses



(655,153)




(864,052)




(121,373)



Loss from operations



(141,328)




(83,570)




(11,739)



Financial income



7,722




11,701




1,644



Foreign currency exchange gain (loss)



12,825




(3,973)




(558)



(Loss) income from equity method investments, net



(6,510)




254




36



Other income, net



6,239




4,903




689



Loss before income tax expenses



(121,052)




(70,685)




(9,928)



Income tax (expenses) benefits



(4)




310




44



Net loss



(121,056)




(70,375)




(9,884)



Net (income) loss attributable to non-controlling interests and
redeemable non-controlling interests



(11)




4,413




620



Net loss attributable to Yatsen's shareholders



(121,067)




(65,962)




(9,264)



Shares used in calculating loss per share (1):











Weighted average number of Class A and Class B ordinary shares:











    Basic



1,986,538,509




1,877,659,636




1,877,659,636



    Diluted



1,986,538,509




1,877,659,636




1,877,659,636



Net loss per Class A and Class B ordinary share











    Basic



(0.06)




(0.04)




(0.00)



    Diluted



(0.06)




(0.04)




(0.00)



Net loss per ADS (20 ordinary shares equal to 1 ADS)











    Basic



(1.22)




(0.70)




(0.10)



    Diluted



(1.22)




(0.70)




(0.10)



 



For the Three Months Ended September 30,





2024



2025



2025



Share-based compensation expenses are included in the
operating expenses as follows:


RMB'000



RMB'000



USD'000



Fulfilment expenses



252




20




3



Selling and marketing expenses



2,289




996




140



General and administrative expenses



23,743




9,337




1,312



Research and development expenses



763




2,108




296



Total



27,047




12,461




1,751



(1)   Authorized share capital is re-classified and re-designated into Class A ordinary shares and Class B ordinary shares, with each Class A ordinary share being entitled to one vote and each Class B ordinary share being entitled to twenty votes on all matters that are subject to shareholder vote.

 

 

YATSEN HOLDING LIMITED

UNAUDITED RECONCILIATIONS OF GAAP AND NON-GAAP RESULTS

(All amounts in thousands, except for share, per share data or otherwise noted)








For the Three Months Ended September 30,





2024



2025



2025





RMB'000



RMB'000



USD'000



Loss from operations



(141,328)




(83,570)




(11,739)



Share-based compensation expenses



27,047




12,461




1,751



Amortization of intangible assets resulting from assets and business
acquisitions



15,779




10,519




1,478



Non-GAAP loss from operations



(98,502)




(60,590)




(8,510)



Net loss



(121,056)




(70,375)




(9,884)



Share-based compensation expenses



27,047




12,461




1,751



Amortization of intangible assets resulting from assets and business
acquisitions



15,779




10,519




1,478



Revaluation of investments on the share of equity method
investments



3,266




(3,213)




(451)



Tax effects on non-GAAP adjustments



(1,586)




(866)




(122)



Non-GAAP net loss



(76,550)




(51,474)




(7,228)



Net loss attributable to Yatsen's shareholders



(121,067)




(65,962)




(9,264)



Share-based compensation expenses



27,047




12,461




1,751



Amortization of intangible assets resulting from assets and business
acquisitions



15,385




10,240




1,438



Revaluation of investments on the share of equity method
investments



3,266




(3,213)




(451)



Tax effects on non-GAAP adjustments



(1,559)




(866)




(122)



Non-GAAP net loss attributable to Yatsen's shareholders



(76,928)




(47,340)




(6,648)



Shares used in calculating loss per share:











Weighted average number of Class A and Class B ordinary shares:











    Basic



1,986,538,509




1,877,659,636




1,877,659,636



    Diluted



1,986,538,509




1,877,659,636




1,877,659,636



Non-GAAP net loss attributable to ordinary shareholders per
Class A and Class B ordinary share











    Basic



(0.04)




(0.03)




(0.00)



    Diluted



(0.04)




(0.03)




(0.00)



Non-GAAP net loss attributable to ordinary shareholders per
ADS (20 ordinary shares equal to 1 ADS)











    Basic



(0.77)




(0.50)




(0.07)



    Diluted



(0.77)




(0.50)




(0.07)



 

Cision View original content:https://www.prnewswire.com/news-releases/yatsen-announces-third-quarter-2025-financial-results-302616686.html

SOURCE Yatsen Holding Limited

FAQ

What were Yatsen (YSG) total net revenues for Q3 2025 and the YoY change?

Yatsen reported total net revenues of RMB998.4 million for Q3 2025, a 47.5% increase year over year.

How much did Yatsen's skincare brands contribute in Q3 2025 and what was the growth rate?

Skincare brands generated RMB490.8 million in Q3 2025, an 83.2% increase year over year and 49.2% of total revenues.

Did Yatsen improve profitability in Q3 2025 and by how much did net loss change?

Yes; Q3 2025 net loss narrowed to RMB70.4 million, a 41.9% reduction from the prior year period.

What guidance did Yatsen give for Q4 2025 revenue (YSG)?

Yatsen expects Q4 2025 total net revenues between RMB1.32 billion and RMB1.49 billion, ~+15% to +30% YoY.

How did Yatsen's gross margin and operating expenses change in Q3 2025?

Gross margin rose to 78.2% from 75.9%; operating expenses increased to RMB864.1 million but declined as a percentage of revenue to 86.5%.

What was Yatsen's cash position at September 30, 2025?

As of Sept 30, 2025, cash, restricted cash and short-term investments totaled RMB1.16 billion (US$162.6M).
Yatsen Hldg Ltd

NYSE:YSG

YSG Rankings

YSG Latest News

YSG Latest SEC Filings

YSG Stock Data

623.15M
61.53M
3.58%
25.85%
1.59%
Household & Personal Products
Consumer Defensive
Link
China
Guangzhou